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Londa Schiebinger, PHD,y Marcia L. Stefanick, PHDzSEE PAGE 127I n recent years, the National Institutes of Health(NIH) has re-energized a focus on the importanceof rigor and reproducibility in research, which
includes blinding, randomization, replication,
adequate sample size, and the importance of sex as
a biological variable in experimental outcomes of
preclinical, clinical, and population health studies
(1,2). According to the NIH, both sex (biological char-
acteristics) and gender (cultural attitudes and behav-
iors) “play a role in how health and disease processes
differ among individuals, and consideration of these
factors in research studies informs the development
and testing of preventive and therapeutic interven-
tions in both sexes.” In recognition of the importance
of these factors, the NIH released a Guide notice in
June 2015 that highlighted the NIH expectation that
sex and gender be factored into research designs, an-
alyses, and reporting of results (3). Well ahead of the
NIH, the Canadian Institutes of Health Research has
explicitly called for sex and gender analysis in health
research since 2010 (4), and the European Commis-
sion has done so since 2013 (5). Nonetheless, the
role of gender and the interaction of gender with bio-
logical sex have generally been neglected in biomed-
ical research.
Among the many biological and medical disci-
plines, cardiovascular researchers have been leaders
in recognizing and investigating differences between
men and women in epidemiology, pathophysiology,*Editorials published in the Journal of the American College of Cardiology
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paper to disclose.clinical manifestations, effects of therapy, and
problems introduced in the diagnosis, treatment, and
management of cardiovascular diseases by assump-
tions based on gender biases of clinicians, leading to
differences in health outcomes (6–8). Yet, despite a
vast and growing literature on differences between
men and women in ischemic heart disease, heart
failure, hypertension, and valvular heart disease (9),
the relative contributions of biological sex versus
sociocultural, gender-related variables remain largely
unexplored. This arises in part from the fact that the
research community has not sufﬁciently addressed
how to study gender in biomedical research.
Sex analysis in research includes reporting the sex
of the subject, analyzing data by sex, and reporting
results and is increasingly the topic of intense
research. Whereas biological sex differences are
initiated by genes encoded on the sex chromosomes,
all other factors (e.g., autosomal and mitochondrial
genes) are believed to be equally inherited by males
and females. However, many characteristics that are
affected by biological sex are continuous and have
overlapping distributions. For instance, men may be
taller on average than women, but there is great
overlap. Researchers understand well how to quan-
tify sex variables in ways that allow for rigorous sta-
tistical analysis (10).Gender, by contrast, is less well understood in
health research. In particular, we lack agreed-upon
methods for measuring gender in ways that can be
analyzed statistically. Hence, our excitement to read
the paper by Pelletier et al. (11) in this issue of the
Journal. The study used a composite measure of
gender recently reported by the lead and senior au-
thors of the paper, Roxanne Pelletier and Louise
Pilote, to be associated with health-related quality of
life (12) and risk factors in patients with premature
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137acute coronary syndrome (ACS) in the GENESIS-
PRAXY (Gender and Sex Determinants of Cardiovas-
cular Disease: From Bench to Beyond-Premature
Acute Coronary Syndrome) cohort (13).
Gender, in their analyses, referred to sociocultural
values and roles that shape expected behaviors of
men and women. Social factors and behaviors often
inﬂuence biology such that gender becomes a modi-
ﬁer of biology (or sex). Gender refers to cultural at-
titudes that are learned and vary by culture,
historical era, ethnicity, socioeconomic status,
geographic location, and other factors (the interac-
tion between gender and ethnicity, for example, is
important to take into account). Gendered attitudes
and behaviors exist on a continuum, and both
masculine and feminine behaviors may manifest in
any one individual and change over the life course
(gendered behaviors change from childhood to
adolescence to adulthood and old age). Of course,
gender does not necessarily match sex, which the
Pelletier et al. study in this issue showed beautifully.
Gender includes gender identity (how individuals and
groups perceive and present themselves), gender
norms (unspoken rules in the family, workplace,
institutional, or global culture that inﬂuence indi-
vidual attitudes and behaviors), and gender relations
(the power relations between individuals of different
gender identities) (14).
Gender is not one thing we measure in the course
of a study, but a cascade of questions and factors
governing research methods. First, when a study is
designed, it is important to consider whether the in-
vestigators’ assumptions about gender play a role in
the selection of study subjects. Assumptions about
the role of hormones or disease states, for example,
may inﬂuence choices concerning which sex to test;
an erroneous assumption in subject choice has con-
sequences for the study as a whole, especially when
sex is included as a biological variable (Gillian Ein-
stein, personal communication, October 2015). For
example, researchers may assume that testosterone is
a male hormone only, even when changes in the brain
due to testosterone administration are noted in fe-
males too. Such assumptions may lead to a decision
to test the relationship between testosterone and
aggression in males only (15). In this case, potentially
important data concerning these relationships in
females would be missed. Similarly, genderedassumptions about a particular disease state may in-
ﬂuence the sex of study subjects. For example, re-
searchers’ assumption that breast cancer is a female
disease has led to the development of female-only
animal models, thus eliminating the opportunity to
better understand breast cancer in males (16,17).
Second, researchers will want to consider the
impact of social environmental factors (i.e., gender)
on the health of the individual. We might call these
the “biologic expressions of gender” (18). Lifestyle
behaviors, such as smoking, a leading cause of car-
diovascular disease and cancer; physical activity;
dietary habits; alcohol consumption; and other
well-known cardiovascular risk factors, differ signif-
icantly between men and women in the U.S. and
other populations (19). Although these behaviors
differ by racial/ethnic group, socioeconomic status,
age, and other factors, men generally have higher
smoking rates, are more physically active, consume
fewer vegetables and fruits and more alcohol, etc.
Pelletier et al. (11) developed new methodology to
analyze gender as a variable to understand the asso-
ciation between gender, sex, and cardiovascular risk
factors among patients with premature ACS. Impor-
tantly, they found no sex differences (i.e., being a
man or a woman did not predict accurately which
patients were likely to relapse or die within 12 months
from diagnosis). The team found, however, that
gender mattered: patients received a gender-related
score of between 1 and 100 points. Patients with a
higher “femininity” score—regardless whether they
were a man or a woman—were more likely to experi-
ence a recurrence of ACS. This study showed that a
man with a high femininity score was more likely to
suffer a recurrence, and a woman with a high mas-
culinity score was not.
We see this as an innovative methodology.
Although more and more studies are addressing the
importance of gender factors in health, methods for
measuring gender need further development. As the
investigators concluded, “there exists no gold stan-
dard for gender.” This is something that now needs to
be developed.
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